ResearcherNational Cancer Center Research InstituteNo recent work listed

Luc Gailhouste

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4489-0522; OpenAlex author ID A5042054413. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper

Papers 1

Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells. Co-author DOI 10.1038/s41419-018-0487-z ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hitoshi Nakagama · 1 shared paper, 2018 · strength 0.11
- Paper Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells. DOI 10.1038/s41419-018-0487-z ↗
Takahiro Ochiya · 1 shared paper, 2018 · strength 0.11
- Paper Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells. DOI 10.1038/s41419-018-0487-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.